Salix Pharmaceuticals Ltd (SLXP)

172.81
0.16 0.09
NASDAQ : Health Care
Prev Close 172.65
Open 172.72
Day Low/High 172.71 / 172.96
52 Wk Low/High 86.00 / 172.98
Volume 4.30M
Avg Volume 3.38M
Exchange NASDAQ
Shares Outstanding 64.25M
Market Cap 11.10B
EPS -6.53
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Put Agenus, Progenics on Your Small-Cap List

Both have good capital appreciation potential.

2 Small Biopharma Stocks on the Move

The oversold biotech sector is recovering.

First-Quarter Deals Near $1 Trillion Mark Highest Value Since 2007

First-Quarter Deals Near $1 Trillion Mark Highest Value Since 2007

Mega deals from strategic players across a variety of industries pushed first-quarter deals to the highest value since 2007.

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

The recent bid by Mylan to acquire Perrigo offers the latest example of pharma companies that have been seeking growth opportunities.

Mylan Bids $29 Billion for Perrigo in Latest Big Pharma Deal

Mylan Bids $29 Billion for Perrigo in Latest Big Pharma Deal

Mylan made public on Wednesday that it had made a proposal to acquire generic drugmaker Perrigo in a deal valued at $205 per share in cash and stock.

Betting the Underdog Can Be Profitable

Winners don't always pay the best.

Market News: Valeant, Salix, Life Time Fitness, Edwards Lifesciences

Market News: Valeant, Salix, Life Time Fitness, Edwards Lifesciences

The stock markets in the United States gained as investors evaluate the timing of interest rate hikes following the release of economic data that missed expectations. The markets also benefited amid c...

Stocks Rebound After Rocky Week As Oil Prices Plummet

Stocks Rebound After Rocky Week As Oil Prices Plummet

Stocks held onto session highs Monday ahead of the Federal Reserve's two-day policy meeting beginning on Tuesday.

Stocks Extend Session Highs as Wall Street Gears Up For Fed Meeting

Stocks Extend Session Highs as Wall Street Gears Up For Fed Meeting

Stocks hold onto session highs by midafternoon Monday ahead of the Federal Reserve's two-day policy meeting that begins Tuesday.

Valeant Boosts Offer for Salix to $15.8 Billion, Endo Drops Bid

Valeant Boosts Offer for Salix to $15.8 Billion, Endo Drops Bid

Valeant comes out on top, following a competing bid from Endo International for the gastrointestinal drugmaker Salix.

Stocks Follow Europe, China Higher; Oil Tumbles to 6-Year Low

Stocks Follow Europe, China Higher; Oil Tumbles to 6-Year Low

Stocks surge on Monday, following European and Asian markets higher.

Salix Pharmaceuticals (SLXP) Stock Higher Today as Valeant Ups Acquisition Bid

Salix Pharmaceuticals (SLXP) Stock Higher Today as Valeant Ups Acquisition Bid

Shares of Salix Pharmaceuticals (SLXP) are up as Valeant Pharmaceuticals increased the offer price to acquire all of the company to $173 from $158 per share in cash.

Stock Futures Are Snapping Back Ahead of Federal Reserve Meeting

Stock Futures Are Snapping Back Ahead of Federal Reserve Meeting

Stock futures are kicking the week off in better fashion than the past few trading sessions, though worries ahead of Wednesday's Federal Reserve policy statement linger.

Valeant And Salix Agree On Amended Terms To Merger Agreement

Valeant And Salix Agree On Amended Terms To Merger Agreement

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) and Salix Pharmaceuticals, Ltd.

Salix Pharmaceuticals (SLXP) Stock Closed Lower Today as Valeant Looks to Increase Bid

Salix Pharmaceuticals (SLXP) Stock Closed Lower Today as Valeant Looks to Increase Bid

Shares of Salix Pharmaceuticals (SLXP) were down as Valeant Pharmaceuticals (VRX) reportedly plans to raise its offer for the company.

March 13 Premarket Briefing: 10 Things You Should Know

March 13 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are down slightly on Friday, as investors anticipate consumer sentiment data and next week's Federal Reserve Open Market Committee meeting.

Insider Trading Alert - EQIX, SLXP And ISR Traded By Insiders

Insider Trading Alert - EQIX, SLXP And ISR Traded By Insiders

Stocks with insider trader activity include EQIX, SLXP and ISR

Stock Futures Post Modest Gains; Retail Sales Decline for Third Month

Stock Futures Post Modest Gains; Retail Sales Decline for Third Month

Stock futures post modest gains on Thursday morning in an attempted recovery after two days of losses which wiped out Wall Street's year-to-date gains.

Endo Raises Buyout Offer for Salix Pharmaceuticals in This Letter to Salix Chairman

Endo Raises Buyout Offer for Salix Pharmaceuticals in This Letter to Salix Chairman

Endo International threw a wrench in the Valeant Pharmaceuticals' $10 billion buyout agreement for Salix Pharmaceuticals, swooping in with a higher buyout offer.

Russell Flexes Its Muscles

Market has timid reaction to Tuesday's slide.

Stocks Struggle to Recover but Fed Rate Hike Worries Persist

Stocks Struggle to Recover but Fed Rate Hike Worries Persist

They get an A for effort, but stocks never managed to recover from Tuesday's brutal selloff.

Salix Pharmaceuticals, Ltd. Confirms Receipt Of An Unsolicited Proposal From Endo International Plc

Salix Pharmaceuticals, Ltd. Confirms Receipt Of An Unsolicited Proposal From Endo International Plc

Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) ("Salix" or the "Company") today confirmed that it has received an unsolicited proposal from Endo International plc ("Endo") to acquire all of the outstanding shares of common...

Salix Pharmaceuticals (SLXP) Stock Surges Today After Endo Makes $11 Billion Bid

Salix Pharmaceuticals (SLXP) Stock Surges Today After Endo Makes $11 Billion Bid

Shares of Salix Pharmaceuticals (SLXP) are up after Endo International (ENDP) made a takeover offer for the company, seeking to wrest it from Valeant Pharmaceuticals (VRX).

3 Drugs Stocks On The Rise

3 Drugs Stocks On The Rise

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

6 Health Care Stocks John Paulson Is Betting On for 2015

6 Health Care Stocks John Paulson Is Betting On for 2015

Here's a closer look at five health care stocks Paulson & Co. bought in the most recently reported quarter.